Rating Change
Canaccord Genuity reiterated its Hold rating on Caris Life Sciences, Inc. (NASDAQ:CAI) on October 19, 2026.
reiterateNASDAQ:CAI
Canaccord Genuity Reiterates Hold Rating on Caris Life Sciences, Inc. (CAI)
Canaccord Genuity reiterated its Hold rating on Caris Life Sciences, Inc. (NASDAQ:CAI) on October 19, 2026.
At publication ·
What changed
Caris Life Sciences, Inc. (NASDAQ:CAI) · reiterate
- Firm
- Canaccord Genuity
- Rating
- Hold to Hold
- Price at event
- $30.83
- Market capitalization
- $7.5B
At a glance
Key takeaways
- Canaccord Genuity maintained a Hold rating on Caris Life Sciences (CAI) on October 19, 2026, with the stock trading at $30.83 and a market cap of $7.5 billion.
Market Context
Caris Life Sciences, Inc. operates in the Healthcare sector. The stock currently trades at $30.83 with a market capitalization of $7.5B. The stock has gained 9.3% over the past 52 weeks.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Caris Life Sciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Caris Life Sciences, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 19, 2026 | Canaccord Genuity | Hold | N/A |
| Oct 14, 2026 | JP Morgan | Overweight | N/A |
| Oct 13, 2026 | TD Cowen | Buy | N/A |
| Sep 09, 2026 | UBS | Neutral | N/A |
| Aug 06, 2026 | Evercore ISI Group | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View CAI Stock Page
Frequently Asked Questions
What does the Hold rating mean for CAI?
A rating of Hold from Canaccord Genuity reflects the analyst's outlook on Caris Life Sciences, Inc. (NASDAQ:CAI). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CAI forecast page.